Brisbane Technology Park
Suite 1.11, Level 1
1 Westlink Court
Darra QLD 4076 Australia
Zucero Therapeutics is committed to the discovery and development of modified sugar compounds for the treatment of cancer and inflammatory conditions.
Zucero’s first clinical candidate is called pixatimod and enhances the ability of the immune system to recognise and destroy cancer.